Molecular signature for clinical outcome prediction.
We use genomic profiling to identify molecular signatures to predict clinical outcome of liver diseases.

---

Molecular classification of liver cancer to guide personalized treatment.
We use molecular classification of liver cancer to predict response to molecular targeted drugs.

---

Nanotechnology-based drug delivery for treatment of liver cirrhosis and cancer.
We develop nanoparticles for more effective and less toxic treatment of liver diseases.

---

Internal lab page